Lidocaine Hydrochloride → Lidocaine

HRID 240243

反応式

HRID 240243 の反応式
[CH3:1][CH2:2][N:3]([CH2:6][C:7]([NH:9][C:10]1[C:11]([CH3:17])=[CH:12][CH:13]=[CH:14][C:15]=1[CH3:16])=[O:8])[CH2:4][CH3:5].Cl.[OH-].[Na+]>O>[CH3:5][CH2:4][N:3]([CH2:6][C:7]([NH:9][C:10]1[C:15]([CH3:16])=[CH:14][CH:13]=[CH:12][C:11]=1[CH3:17])=[O:8])[CH2:2][CH3:1]

参加物

4

反応物 2

HCID 6314Lidocaine HydrochlorideHCID 14798Sodium Hydroxide

生成物 1

HCID 3676Lidocaine

試薬・触媒・溶媒 1

HCID 962Water溶媒2 回

実験手順

Sodium chondroitin sulfate (1 g) and lidocaine hydrochloride (2 g) were dissolved in distilled water for injection (80 ml). After being adjusted to pH 7 by addition of a sufficient quantity of sodium hydroxide, the solution was added with distilled water for injection up to the total volume of 100 ml to prepare the composition for local anesthesia of the present invention.

後処理

  1. customto prepare the composition for local anesthesia of the present invention

出典と根拠

ORDレコード
ord-66162956cfa24f8bac1758923999308d
出典データセット
uspto-grants-2014_02
特許番号
US08648056B2

関連ノート

読み込み中…